In comparison with reports evaluating the association between N-cadherin and urothelial carcinoma of bladder, the percentage of expression of N-cadherin in UTUC in this study was within the range detected in bladder cancer reports [24–26] and lower than the previously reported in UTUC (43 vs 68%) [13]. The gene discussed is CDH2; the disease is urinary bladder cancer.